Cutler Group LP Graybug Vision, Inc. Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022
SELL
$1.13 - $1.93 $2,669 - $4,558
-2,362 Reduced 92.19%
200 $0
Q4 2021

Jan 18, 2022
SELL
$1.74 - $3.6 $1,336 - $2,764
-768 Reduced 23.06%
2,562 $4,000
Q3 2021

Oct 26, 2021
SELL
$3.18 - $5.17 $5,946 - $9,667
-1,870 Reduced 35.96%
3,330 $11,000
Q2 2021

Jul 19, 2021
BUY
$3.53 - $6.1 $18,356 - $31,719
5,200 New
5,200 $28,000

Others Institutions Holding GRAY

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About GRAYBUG VISION, INC.

GRAY Quotes by TradingView
  • Ticker GRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,517,700
  • Market Cap $63.5M
  • Description
  • Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...
More about GRAY
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email